When Metformin Remains a First-Line Choice Metformin remains the standard initial medication for type 2 diabetes because it is affordable, well-tolerated, has decades of safety data, and addresses insulin resistancethe root driver of many metabolic disorders
Real-world effectiveness Studies examining real-world outcomes show that results are typically somewhat lower than in clinical trials but still significant: A 2025 Cleveland Clinic study found average weight loss of 10-15% in routine clinical practice (compared to 15-22% in trials)
Typically, patients of our weight loss program in Stockton, California who start FDA-approved GLP-1 medications like Ozempic and Wegovy lose an average 15% of their weight when combined with diet and exercise
A yearly review happens because prescribing guidelines are adjusted for medicines or supplies, new drugs become available or some are removed
MOTS-c is also contraindicated for people who take AMPK-activating medicines, such as metformin , thiazolidinediones , and aspirin , as well as anyone with an active cancer diagnosis and people who are pregnant or breastfeeding
See what do peptides do
